Adrenal insufficiency, diseases associated w/ heart block; hypoparathyroidism, acute dehydration, pancreatitis, rhabdomyolysis, extensive tissue damage eg, severe burns; osteomalacia, rickets, myotonia congenita, heart disease particularly in digitalised patients; hypocalcaemia. Bone binding sites saturation. Monitor serum Na, K, phosphate, Ca conc & renal function every 12-24 hr during therapy. Avoid monobasic K phosphates in hyperkalaemic patients. Not to be administered concomitantly w/ Al, Ca or Mg salts. Chronic renal disease, severe renal insufficiency. Not recommended during pregnancy & lactation.